Tobacco Law Means Drug Sponsor Opportunities May Not Stop At Cessation
This article was originally published in The Tan Sheet
Executive Summary
The tobacco control act prompts FDA to consider new indications - such as smoking reduction - for smoking cessation products, which could lead to new criteria for application approval